Correspondence to editorial on “Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma”

키워드

참고문헌 (15)

1. Ahn JC, "Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma : A gateway to personalized medicine : Editorial on"Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma"", Clin Mol Hepatol, 30, pp.689~691 (2024)
2. Hong J, "Multiomics profiling of buffy coat and plasma unveils etiologyspecific signatures in hepatocellular carcinoma", Clin Mol Hepatol, 30, pp.360~374 (2024)
3. Finn RS, "Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240 : A randomized, double-blind, phase III trial", J Clin Oncol, 38, pp.193~202 (2020)
4. Qin S, "Pembrolizumab versus placebo as second-line therapy in patients from Asia with advanced hepatocellular carcinoma : A randomized, double-blind, phase III trial", J Clin Oncol, 41, pp.1434~1443 (2023)
5. Zheng Q, "Singlecell landscape identifies the immunophenotypes and microenvironments of HBV-positive and HBV-negative liver cancer", Hepatol Commun, 8, pp.e0364~ (2024)
6. Diniz MO, "NK cells limit therapeutic vaccine-induced CD8+T cell immunity in a PD-L1-dependent manner", Sci Transl Med, 14, pp.eabi4670~ (2022)
7. Sogbe M, "Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment", Clin Mol Hepatol, 30, pp.177~190 (2024)
8. Lim SB, "An extracellular matrixrelated prognostic and predictive indicator for early-stage nonsmall cell lung cancer", Nat Commun, 8, pp.1734~ (2017)
9. Kui X, "Prognostic value of SH3PXD2B(Tks4)in human hepatocellular carcinoma : a combined multi-omics and experimental study", BMC Med Genomics, 14, pp.115~ (2021)
10. Flieswasser T, "The CD70-CD27 axis in oncology : the new kids on the block", J Exp Clin Cancer Res, 41, pp.12~ (2022)
11. Dong MP, "Soluble immune checkpoint protein CD27 is a novel prognostic biomarker of hepatocellular carcinoma development in hepatitis C virus-sustained virological response patients", Am J Pathol, 192, pp.1379~1396 (2022)
12. Kong F, "Abstract 5629 : MEF2D regulates T cell function via the CD70-CD27 signaling axis and promotes immune escape in hepatocellular carcinomas", Cancer Res, 84(6 Suppl), pp.5629~ (2024)
13. Sohn W, "Correspondence on Editorial regarding"Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease"", Clin Mol Hepatol, 29, pp.182~184 (2023)
14. Lee SH, "Deep learning-based prediction of molecular cancer biomarkers from tissue slides : A new tool for precision oncology", Clin Mol Hepatol, 28, pp.754~772 (2022)
15. Oh S, "Identification of signature gene set as highly accurate determination of metabolic dysfunction-associated steatotic liver disease progression", Clin Mol Hepatol, 30, pp.247~262 (2024)

관련 논문AI추천